200 related articles for article (PubMed ID: 3933351)
1. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
Skouby SO; Kühl C; Mølsted-Pedersen L; Petersen K; Christensen MS
Am J Obstet Gynecol; 1985 Nov; 153(5):495-500. PubMed ID: 3933351
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
Skouby SO; Andersen O; Kühl C
Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
[TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
4. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Kung AW; Ma JT; Wong VC; Li DF; Ng MM; Wang CC; Lam KS; Young RT; Ma HK
Contraception; 1987 Mar; 35(3):257-69. PubMed ID: 3111786
[TBL] [Abstract][Full Text] [Related]
5. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
[TBL] [Abstract][Full Text] [Related]
7. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Skouby SO; Andersen O; Saurbrey N; Kühl C
J Clin Endocrinol Metab; 1987 Mar; 64(3):519-23. PubMed ID: 3102539
[TBL] [Abstract][Full Text] [Related]
8. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Skouby SO; Wagner HH; Andersen O
Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
[TBL] [Abstract][Full Text] [Related]
9. Contraception for women with diabetes: an update.
Skouby SO; Mølsted-Pedersen L; Petersen KR
Baillieres Clin Obstet Gynaecol; 1991 Jun; 5(2):493-503. PubMed ID: 1954724
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new triphasic oral contraceptive in private practice.
Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
[TBL] [Abstract][Full Text] [Related]
12. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
14. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
15. New progestogens in oral contraceptives.
Runnebaum B; Rabe T
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
[TBL] [Abstract][Full Text] [Related]
16. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of two triphasic formulations containing ethinyl estradiol and dl-norgestrel.
Smith RP; Sizto R
Contraception; 1983 Aug; 28(2):189-99. PubMed ID: 6641221
[TBL] [Abstract][Full Text] [Related]
18. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.
Skouby SO; Mølsted-Pedersen L; Kühl C; Bennet P
Fertil Steril; 1986 Nov; 46(5):858-64. PubMed ID: 3781003
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Petersen KR; Skouby SO; Dreisler A; Kühl C
Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]